Materials

N,N-Dimethylformamide
(TCI, Tokyo, Japan). Diethyl ether was purchased from Showa-Ether (Tokyo, Japan). Lithium chloride was purchased from Nacalai Tesque (Kyoto, Japan). UltraPure TM Agarose, Lipofectamine ® 2000, and Lipofectamine ® 3000 were purchased from ThermoFisher Scientific (Waltham, MA, USA). Fetal bovine serum (FBS) was purchased from Biosera (Nuaille, France).
HEPES (1 M, pH 7.3) was purchased from Amresco (Solon, OH, USA). DMF, n-butylamine,
and DET were distilled with the conventional methods before use. C2C12 (mouse myoblast cell line), Neuro-2a (mouse neuroblastoma cell line), and HeLa (human cervical cancer cell line) cells were obtained from the American Type Culture Collection (Manassas, VA, USA). Gaussia luciferase (GLuc) and firefly luciferase (FLuc) mRNAs were kindly donated by Dr. Satoshi
Uchida (The University of Tokyo). Briefly, these mRNAs were synthesized by mMessage mMachine TM T7 ULTRA Transcription Kit (ThermoFisher Scientific) as previously reported [12] . Label IT Cy3 Labeling Kit and Label IT Cy5 Labeling Kit (Mirus Bio Corporation, Madison, WI, USA) were used to attach the fluorescent dyes to GLuc-mRNA and sgRNA. A STOP cassette-targeting sgRNA was synthesized by TriLink BioTechnologies, Inc. (San Diego, CA, USA): (5´-aag UAA AAC CUC UAC AAA UGG UUU UAG AGC UAG AAA UAG CAA GUU AAA AUA AGG CUA GUC CGU UAU CAA CUU GAA AAA GUG GCA CCG AGU CGG UGC uuu U-3´) [34, 35] . Uppercase letters denote RNA. Lowercase letters and underlines indicate phosphorothioate and 2´-O-methyl-modified RNA.
Synthesis of poly(β-benzyl-L-aspartate) (PBLA)
β-Benzyl-L-aspartate N-carboxy-anhydride (BLA-NCA) was purchased from Chuo Kaseihin Co., Inc. (Tokyo, Japan). PBLA was synthesized by the ring-opening polymerization of the BLA-NCA initiated by n-butylamine as previously reported [11] . Briefly, n-butylamine (6.56 μL, 0.0664 mmol) in DCM (660 μL) was added to BLA-NCA (410 mg, 1.66 mmol) dissolved in 6 mL of DCM/DMF (9:1 v/v). The polymerization proceeded for 48 h at 37 °C under argon atmosphere. The resulting polymer was precipitated in hexane/ethyl acetate (6:4 v/v) and dried overnight under reduced pressure. The prepared PBLA was characterized by gel permeation chromatography (GPC) and 1 H NMR (400 MHz, ECS-400, JEOL, Tokyo, Japan). The GPC system (HLC-8220, TOSOH CORPORATION, Tokyo, Japan) equipped with two TSK gel columns (TSK-gel Super AW4000 and Super AW3000) was eluted with DMF containing lithium chloride (10 mM) at 0.8 mL/min. A molecular weight distribution (Mw/Mn) of PBLA was determined to be 1.18 from the GPC chart ( Figure S1A ). A degree of polymerization of benzyl-L-aspartate (BLA) unit in PBLA was calculated to be 26 from the peak intensity ratio of the phenyl protons (COOCH2C6H5, δ = 7.2-7.3) to the methyl protons (CH3(CH2)3NH, δ = 0.8) in the 1 H NMR spectrum ( Figure S1B ). The PBLAs with DP = 63 and 121 were similarly synthesized to evaluate the effect of DP of polyaspartamide derivatives and their Mw/Mn values were determined to be 1.19 and 1.34, respectively.
Synthesis of amphiphilic polyaspartamide derivatives with diethylenetriamine moieties (PAsp(DET/R))
A series of PAsp(DET/R)s were prepared by the simultaneous aminolysis reaction of PBLA with DET and varying aliphatic amines [11] . For the synthesis of PAsp(DET/CHE) (DP = 26), PBLA (DP = 26, 30 mg) was dissolved in NMP (2 mL) and cooled to 4 °C. The PBLA solution was dropwised to the mixture of DET (790 μL) and 2-cyclohexylethylamine (2.14 mL) (molar ratio = 1:2). The solution was stirred for 1 h at 4 °C under argon atmosphere. The reaction mixture was dropwised to cold 5 M HCl (5 mL) for neutralization. The polymer product was purified by dialysis against 0.01 M HCl and then distilled water at 4 °C. The dialyzed solution was lyophilized to obtain a solid powder. The powder was dissolved in MeOH (4 mL) with a small amount of triethylamine and then precipitated into an excess amount of diethyl ether to completely remove unreacted 2-cyclohexylehtylamine. The precipitate was filtered and dissolved in distilled water. The polymer was further purified by dialysis against 0.01 M HCl and then distilled water at 4 °C. The dialyzed solution was lyophilized to obtain the final product.
Quantitative conversion of benzyl ester groups to diethylenetriamine (DET) and 2-cyclohexylethy (CHE) moieties in side chains was confirmed in the 1 H NMR spectrum (10 mg/mL, 80 °C) ( Figure S2 ). The other PAsp(DET/R)s were further prepared according to the similar procedures. The quantitative conversions of benzyl ester groups to aliphatic moieties, e.g., pentyl (PEN), heptyl (HEP), octyl (OCT), nonyl (NON), and decyl (DEC), were confirmed from the peak intensity ratio between alkyl protons in hydrophobic moieties (-CH2-or CH3-,  = 0.9-1.5 ppm) and methine protons in polymer backbone (-COCHNH-,  = 4.6-4.8 ppm) in the 1 H NMR spectra ( Figure S3 for PAsp(DET/OCT)). An introduction rate of 2-phenylethyl (PHE) moieties was calculated from the peak intensity ratio between phenyl protons (Ph-,  = 7.0-7.5 ppm) and methine protons in polymer backbone (-COCHNH-,  = 4.6-4.8 ppm) in the 1 H NMR spectrum ( Figure S4 ). PAsp(DET/CHE)s with lower introduction rates of CHE moieties were prepared by reacting PBLA (DP = 26) with the mixtures at diethylenetriamine:2-cyclohexylethylamine = 4.5:1 and 1.2:1 in molar ratio. Also, PBLAs with DP = 63 and 121 were reacted with the mixture at DET:2-cyclohexylethylamine = 1:2. The introduction rates of CHE and DET moieties in these PAsp(DET/CHE)s were similarly determined from the peak intensity ratio in the 1 H NMR spectra (data not shown).
Octanol-water partition coefficient measurement
Octanol-water partition coefficients (log P) of PAsp(DET/R) series were determined in the 1:1 mixture of 1-octanol/HEPES buffer (10 mM, pH 7.3) [39, 40] . PAsp(DET/R)s were labeled with Alexa Fluor ® 647 dye NHS ester (Alexa647) (ThermoFisher Scientific) in MeOH with a small amount of triethylamine. The obtained Alexa647-labeled PAsp(DET/R)s (100 µM, 50 µL) dissolved in 10 mM HEPES buffer (pH 7.3) were mixed with 1-octanol (50 µL) and the mixtures were vigorously agitated for 30 min (2900 rpm, Eppendorf MixMate, Hamburg, Germany). The biphasic mixtures were shortly centrifuged and placed at 4 °C for 1 h. The 1-octanol phase was carefully collected and further placed at 4 °C for 1 h. The remaining HEPES buffer phase was centrifuged at 3300 g for 5 min and placed at 4 °C for 1 h. The fluorescence intensities of Alexa647 in 1-octanol and HEPES buffer phases were measured by Spectrofluorometer (FP-8300, Jasco, Tokyo, Japan).
Preparation and characterization of IVT mRNA-loaded polyplexes with PAsp(DET/R)s
PAsp(DET/R)s were dissolved in 10 mM HEPES buffer (pH 7.3) and then mixed with IVT mRNA solution (100 ng/μL mRNA in 10 mM HEPES buffer, pH 7.3) to prepare polyplexes (20 ng/μL mRNA) at desired molar ratios of amino groups in DET unit to phosphate groups in mRNA (N/P). Polyplex size (cumulant diameter) and size distribution (polydispersity index (PDI)) were determined by dynamic light scattering using a Zetasizer (Malvern Instruments, Worcestershire, UK) equipped with a He-Ne Laser (λ = 633 nm) at a temperature of 25 °C and a detection angle of 173°. The size measurement was performed in a low volume quartz cuvette (ZEN2112, Malvern Instruments). The data obtained from the rate of decay in the photon correlation function were analyzed by the cumulant method to obtain the corresponding cumulant diameter and PDI. Zeta potential of polyplex was determined with the same apparatus using a folded capillary cell (Malvern Instruments). The zeta potential was calculated from the measured electrophoretic mobility based on the Smoluchowski equation.
Gel retardation analysis.
PAsp(DET/R) and GLuc-mRNA were mixed at N/P ratios of 0, 1, 2, 3, 4, and 5, as Wildbad, Germany).
Cell viability assay
Cell viability was evaluated using a Cell Counting Kit-8 (Dojindo, Kumamoto, Japan).
C2C12 cells were seeded into a 96-well plate (8000 cells/well) in DMEM/FBS. On the next day, polyplex samples prepared from PAsp(DET/CHE) (CHE-polyplexes) and GLuc-mRNA at N/P = 5 were added to the cell at varying concentrations and the cells were incubated for 24 h. The medium was exchanged with a fresh medium (100 µL) containing the kit solution (10 µL) and the cells were further incubated for 1 h. The absorbance of the medium was measured at 4 50 nm using a Spark 20M Multimode Microplate Reader (TECAN, Switzerland).
Flow cytometric analysis
C2C12 cells were seeded into a 12-well plate at a density of 100,000 cells/well in DMEM/FBS. On the next day, the medium was replaced with fresh DMEM/FBS. Polyplex solutions (N/P = 5) containing Cy5-labeled GLuc-mRNA (Cy5-mRNA) were then added to each well (500 ng mRNA/well). After 4-h incubation, the medium was removed and the cells were The polyplex samples were transfected at 500 ng mRNA/well. The cells were stained with
LysoTracker Green (Molecular Probes, Eugene, OR, USA) for 1 h and Hoechst 33342 (Dojindo, Japan) for 5 min. Each dish was observed using a CLSM (ZEISS LSM 780, Carl Zeiss, Oberkochen, Germany) equipped with a C-Apochromat 40× objective (Carl Zeiss).
Homology-directed repair (HDR) efficacy by luciferase reporter system
HeLa cells were seeded into a 96-well black-walled plate at a density of 10,000 cells/well in DMEM/FBS. On the next day, the medium was replaced with fresh DMEM/FBS. Reporter components, i.e., a full-length luciferase donor DNA and two pDNAs encoding sgRNA or StopFluc reporter [28] , were transfected into the cells using Lipofectamine 3000 (Thermo Fischer Scientific) according to the manufacturer's protocol. The cells were incubated for 24 h.
CHE-polyplex (DP = 26, N/P = 5), DET0/121-polyplex (DP = 121, N/P = 5), and Lipofectamine 3000 loaded with SpCas9 mRNA (Miltenyi Biotec Inc., CA, USA) were transfected at 50 ng mRNA/well, and the cells were incubated for 24 h. As a positive control, a pDNA encoding codon-optimized SpCas9 was also transfected into the cells simultaneously with the reporter components using Lipofectamine 3000 and the cells were incubated for total 48 h. Thereafter, the medium was replaced with 100 L of 1× Hank's Balanced Salt Solution (Life technologies)
containing 500 M of D-luciferin (Wako Pure Chemical Industries) as a substrate and the cells were further incubated for 30 min at 37 °C. Luminescence measurements were performed using a luminescence microplate reader (Mithras LB 940).
Intracerebroventricular and intrathecal administrations
For intracerebroventricular injection, 6 to 8-week-old female BALB/c mice (Charles River Laboratories Japan, INC., Yokoyama, Japan) were anesthetized by inhalation of isoflurane (Pfizer, NY, USA), and were held in the prone position on a stereotaxic instrument (Narishige Group, Tokyo, Japan) [41] . The scalp was sagittally incised in the lengths of 1.0-1.5 cm and the calvarium was exposed by blunt dissection. A small parietal hole was perpendicularly created on the sagittal suture of the skull at the 0.5 mm posterior to the bregma by a 1-mm diameter diamond plated points. A polyplex solution (10 μL) containing 4.5 μg FLuc-mRNA was administered to the 3rd ventricle at the depth of 3.0 mm ventral to the surface of the brain with a
Hamilton syringe connected to a stereotaxic micromanipulator (Narishige Group) at a rate of Table S4 . DH, PDI, and zeta potential of polyplexes prepared from varying PAsp(DET/R)s with DP = 26 (mean ± SD, n = 3). were incubated in 10% FBS for 1 h at 37 °C. The remaining mRNA amounts were quantitatively analyzed by Image Lab TM software (Bio-Rad) ( Figure 3A) . 
